NAV
$63.89
AUM
$1.7B
Expense Ratio
-
Dividend Yield
1.02%
Beta
0.90
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +6.70% | +4.87% | +7.86% | +17.33% | +13.84% | +7.62% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ROP.SW | Roche Holding AG Ordinary Shares new | 13.26% |
| 2 | NOVN.SW | Novartis AG Registered Shares | 12.31% |
| 3 | NESN.SW | Nestle SA | 11.62% |
| 4 | ABBN.SW | ABB Ltd | 6.32% |
| 5 | CFR.SW | Compagnie Financiere Richemont SA Class A | 4.76% |
| 6 | UBSG.SW | UBS Group AG Registered Shares | 4.47% |
| 7 | ZURN.SW | Zurich Insurance Group AG | 4.24% |
| 8 | HOLN.SW | Holcim Ltd | 2.77% |
| 9 | LONN.SW | Lonza Group Ltd | 2.48% |
| 10 | SREN.SW | Swiss Re AG | 2.42% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large- and mid- capitalization segments of the equity market in Switzerland. The fund is non-diversified.
Inception Date: 1996-03-12